Vertigo, a perception of self-motion or environmental movement, is a common clinical problem encountered in both primary care and specialty settings. Understanding this complex symptom and implementing an effective treatment strategy can be challenging for healthcare professionals.
Vertigo is often a manifestation of vestibular disorders. It is characterized by a sensation of spinning or feeling off-balance and can be associated with nausea, vomiting, unsteadiness, and problems with coordination. The severity can range from mild, transient episodes to debilitating, chronic conditions that significantly impair quality of life.
The pathophysiology of vertigo is multifaceted, often involving dysfunction in the vestibular system of the inner ear or the central nervous system. Conditions such as benign paroxysmal positional vertigo (BPPV), Meniere's disease, vestibular neuritis, and labyrinthitis are common causes. Central causes include migraines, multiple sclerosis, and stroke.
Assessment of a patient with vertigo involves a detailed history, physical examination, and often specialized testing. The history should focus on the onset, duration, frequency, and triggers of the vertigo. Physical examination should include a thorough neurological and otologic examination. Specialized tests may include audiometry, vestibular function tests, and imaging studies.
Treatment of vertigo is directed towards the underlying cause. This may involve medications, physical therapy, lifestyle modifications, or in some cases, surgery. Patient education and reassurance are also key components of management.
Vertigo is a complex symptom that requires a comprehensive clinical approach for accurate diagnosis and effective management. By understanding its pathophysiology and implementing a thorough assessment strategy, healthcare professionals can provide optimal patient care and improve outcomes for individuals suffering from this challenging condition.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation